Clinical trials in Karlovac

Innovative clinical trials focusing on atherosclerotic cardiovascular disease (ASCVD) are evaluating new therapeutic approaches for patients whose current lipid-modifying treatments aren't providing optimal results.

• Cardiovascular Event Prevention
• Arterial Plaque Management
• Lipid Modification Therapy

Additional research explores treatments for atrial fibrillation, specifically targeting stroke prevention and systemic embolism reduction.

Groundbreaking research targets severe hypertriglyceridemia (SHTG), investigating innovative treatments to manage elevated triglyceride levels in adult patients.

• Triglyceride Level Management
• Metabolic Disease Treatment
• Lipid Disorder Therapy

These trials aim to advance our understanding of metabolic disorders and develop more effective treatment options.

Advanced clinical research explores new treatments for Chronic Obstructive Pulmonary Disease (COPD), focusing on reducing moderate and severe exacerbations through enhanced therapeutic combinations.

• COPD Management
• Respiratory Function
• Triple Therapy Enhancement

Studies evaluate innovative approaches to improve existing maintenance therapies for respiratory conditions.